Skip to main content
Clinical Trials/NCT07294521
NCT07294521
Recruiting
Early Phase 1

Efficacy of Platelet-rich-Fibrin Gel in Patients With Chronic Leg Ulcers

Pak Emirates Military Hospital1 site in 1 country40 target enrollmentStarted: December 16, 2025Last updated:

Overview

Phase
Early Phase 1
Status
Recruiting
Sponsor
Pak Emirates Military Hospital
Enrollment
40
Locations
1
Primary Endpoint
50% improvement in Bates Jensen wound assessment tool (BWAT) score

Overview

Brief Summary

Platelet rich Fibrin (PRF) gel is an emerging as a novel treatment option for chronic leg ulcers and has the potential to become the 1st line option in these conditions. The objective of our study will be to assess the efficacy of PRF gel dressing in patients with non-infective chronic leg ulcers.

Detailed Description

Chronic leg ulcers (CLU) affect approximately 1% of the adult population and the prevalence increases significantly with age. The causes of CLU are mainly non-infective and include neuropathy, venous and arterial disease followed by less common causes like metabolic and hematological disorders. Leg ulcers severely impact the patients' quality of lives and frequently result in impaired mobility and financial dependence. There are several validated tools for the objective assessment of the ulcer severity. Bates Jensen wound assessment tool (BWAT) is one of these measures which will be originally developed for assessing pressure wounds but has been validated for other wounds such as CLU. BWAT consists of 13 scored items and can be used as a comprehensive tool for initial assessment as well as an indicator of treatment response.

The management is mainly supportive and depends on the underlying aetiology but there is a dearth of targeted wound management options that promote healing. Platelet rich Fibrin (PRF) gel is an emerging as a novel treatment option for chronic leg ulcers and has the potential to become the 1st line option in these conditions . The objective of our study will be to assess the efficacy of PRF gel dressing in patients with non-infective chronic leg ulcers.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
35 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • All male and female patients more than 35 years old with Chronic Leg Ulcers, presenting to the OPD will be included.

Exclusion Criteria

  • Patients with clinical signs of infected ulcers, patients in sepsis and immunosuppressed individuals will be excluded.

Arms & Interventions

PRF group

Experimental

Enrolled patients with chronic leg ulcers who will be administered PRF gel

Intervention: Platelet rich Fibrin (PRF) (Biological)

Outcomes

Primary Outcomes

50% improvement in Bates Jensen wound assessment tool (BWAT) score

Time Frame: 1 months

Bates Jensen wound assessment tool (BWAT) is one of these measures which will be originally developed for assessing pressure wounds but has been validated for other wounds such as Chronic leg Ulcer. BWAT consists of 13 scored items and can be used as a comprehensive tool for initial assessment as well as an indicator of treatment response. The score ranges from 9 to 65 with higher scores mean worse healing (tissue degeneration), lower scores indicate improvement (regeneration).

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Pak Emirates Military Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Dr. Ahsan Tameez-ud-din

Registrar Dermatology

Pak Emirates Military Hospital

Study Sites (1)

Loading locations...

Similar Trials